Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:48 am Purchase |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
RTW Investments, LP | 755,482 7.700% |
32,745 (+4.53%) |
Filing History |
| 2022-02-11 4:10 pm Sale |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
ORBIMED ADVISORS LLC | 0 0.000% |
-484,525 (Position Closed) |
Filing History |
| 2022-02-11 4:07 pm Purchase |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
REGENERON PHARMACEUTICALS INC REGN |
180,910 1.840% |
180,910 (New Position) |
Filing History |
| 2022-02-11 10:01 am Sale |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
AVORO CAPITAL ADVISORS LLC | 695,000 7.100% |
-105,000 (-13.12%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
734,682 7.500% |
30,405 (+4.32%) |
Filing History |
| 2021-10-12 12:34 pm Sale |
2021-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
STATE STREET CORP STT |
204,762 2.090% |
-816,324 (-79.95%) |
Filing History |
| 2021-09-10 2:27 pm Purchase |
2021-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
STATE STREET CORP STT |
1,021,086 10.410% |
1,021,086 (New Position) |
Filing History |
| 2021-08-16 4:32 pm Unchanged |
2021-08-16 | 13G | Adverum Biotechnologies, Inc. ADVM |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-04-16 3:11 pm Unchanged |
2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
0 (Unchanged) |
Filing History |
| 2021-04-09 4:54 pm Purchase |
2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
50,000 (+8.15%) |
Filing History |
| 2021-03-18 2:21 pm Purchase |
2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 613,143 6.300% |
91,528 (+17.55%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
RA Capital Management, L.P. | 633,492 9.700% |
633,492 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 521,615 5.400% |
96,887 (+22.81%) |
Filing History |
| 2021-02-12 4:37 pm Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
ORBIMED ADVISORS LLC | 484,525 4.970% |
90,116 (+22.85%) |
Filing History |
| 2021-02-12 09:17 am Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
RTW Investments, LP | 722,736 7.420% |
84,076 (+13.16%) |
Filing History |
| 2021-02-12 08:00 am Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
AVORO CAPITAL ADVISORS LLC | 800,000 8.200% |
275,000 (+52.38%) |
Filing History |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
704,277 7.200% |
252,434 (+55.87%) |
Filing History |
| 2020-12-23 5:17 pm Sale |
2020-12-14 | 13D | Adverum Biotechnologies, Inc. ADVM |
Versant Ventures IV LLC | 500,389 5.100% |
-200,000 (-28.56%) |
Filing History |
| 2020-08-20 2:21 pm Purchase |
2020-08-18 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 424,728 4.400% |
45,172 (+11.90%) |
Filing History |